|
Á¦¸ñ : Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)*
DOI: 10.1097/CCM.0000000000003685
¹ßÇ¥ÀÚ : R2 ÀÌ¿µÃ¤
Supervisor : Á¤°æ¼ö ±³¼ö´Ô
|